GUFIC BIOSCIENCES
Back to All Ratios
|
GUFIC BIOSCIENCES Last 5 Year Receivable days History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Receivable days | 106.89 | 128.09 |
What is the latest Receivable days ratio of GUFIC BIOSCIENCES ?
| Year | Receivable days |
|---|---|
| Mar2025 | 106.89 |
| Mar2024 | 128.09 |
How is Receivable days of GUFIC BIOSCIENCES Trending?
| Years | Receivable days | % Change | |
|---|---|---|---|
| Mar2025 | 106.89 | -16.55 | |
| Mar2024 | 128.09 | - | |
Other Financial Ratios of GUFIC BIOSCIENCES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Receivable days ratio of peers of GUFIC BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUFIC BIOSCIENCES | ₹3,257.7 Cr | -4% | -7.9% | -23.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,452.0 Cr | -0.3% | 6% | -10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,089.0 Cr | 3.9% | 18.6% | 14.5% | Stock Analytics | |
| CIPLA | ₹121,299.0 Cr | -5.2% | NA | 2.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,456.0 Cr | -1% | -1.2% | 8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,965.9 Cr | -6.8% | -2.1% | -8.4% | Stock Analytics | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | -4% |
-7.9% |
-23.8% |
| SENSEX | -0.3% |
4.5% |
5.7% |
You may also like the below Video Courses